Hybridoma technology is a method for producing large quantities of monoclonal antibodies by fusing antibody producing B cells with myeloma cells (cancerous B cells). This creates hybrid cells, hybridomas, that produce the antibody from their parent B cell whilst maintaining the properties of the parental myeloma cell line being immortal (endlessly reproducing) and having desirable properties for cell culture.
Hybridoma technology is a method for producing large quantities of monoclonal antibodies by fusing antibody producing B cells with myeloma cells (cancerous B cells). This creates hybrid cells, hybridomas, that produce the antibody from their parent B cell whilst maintaining the properties of the parental myeloma cell line being immortal (endlessly reproducing) and having desirable properties for cell culture.
Source: Wikipedia "Hybridoma technology" · CC BY-SA 4.0
Share this article: X · Bluesky